August 3, 2016April 4, 2017

Adcetris Shows Promise in Treating Cutaneous T-Cell Lymphoma in Phase 3 Study

News

Adcetris may greatly benefit patients with cutaneous T-cell lymphoma (CTLC) who received prior systemic or radiation therapy, according to Phase 3 clinical trial results recently announced by Takeda Pharmaceutical Company and Seattle Genetics. The study met ... Read more

July 29, 2016September 8, 2016

CNS Lymphoma Standard of Care Should Include Rituxan and Tepadina, Study Suggests

News

Patients with central nervous system (CNS) lymphoma are more likely to achieve complete remission when Rituxan (rituximab) and Tepidina (thiotepa) are added to conventional methotrexate-cytarabine therapy, according to the results of ... Read more